Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Cannabinoids may help some skin conditions but more research is needed.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Apremilast shows promise for several skin conditions but needs more research.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.